Platelet aggregation inhibitors in prevention and treatment of coronary thrombosis.

Abstract

Platelet aggregation plays a key role in the development of complications of atherosclerosis. By inhibiting platelet aggregation in a pharmacological way complications such as myocardial infarction and sudden death may be prevented. This goes for primary as well as secondary prevention. The most relevant substances for this goal are aspirin, clopidogrel and the new glycoprotein IIb/IIIa inhibitors.

• Authors: M E R Gomes, F W A Verheugt
• Journal: The Netherlands journal of medicine (Neth J Med) Vol. 61 Issue 6 Pg. 185-92 (Jun 2003) ISSN: 0300-2977 [Print] Netherlands
• PMID: 12948162 (Publication Type: Journal Article, Review)

Chemical References

• Platelet Aggregation Inhibitors

Topics

• Coronary Thrombosis (drug therapy, physiopathology, prevention & control)
• Humans
• Platelet Aggregation Inhibitors (pharmacology, therapeutic use)